Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Who should not have this treatment
The Tirzepatide segment is expected to grow at the fastest CAGR in the coming years, driven by a dual GIP and GLP-1 receptor mechanism providing better results for weight loss
Despite the dip, Mounjaro remains the costliest therapy in its class, with a starting weekly dose priced at Rs 3,581
GPx activity may have influenced the formation of a smaller amount of superoxide anion radicals in yeast cells, which are primarily removed by other enzymes
Key Takeaways GLP-1 patches are not supported by the same level of evidence as prescription GLP-1 medicines
US$ 27.06
US$ 26.14
US$ 29.88
US$ 25.47
US$ 28.11
US$ 24.69
